Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

EMPAGLIFLOZIN for Diabetes mellitus inadequate control: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 73 adverse event reports in the FDA FAERS database where EMPAGLIFLOZIN was used for Diabetes mellitus inadequate control.

Most Reported Side Effects for EMPAGLIFLOZIN

Side Effect Reports % Deaths Hosp.
Diabetic ketoacidosis 3,644 9.8% 85 2,610
Fungal infection 1,941 5.2% 7 94
Blood glucose increased 1,797 4.9% 4 306
Euglycaemic diabetic ketoacidosis 1,769 4.8% 59 1,340
Weight decreased 1,661 4.5% 25 328
Urinary tract infection 1,439 3.9% 42 687
Ketoacidosis 1,411 3.8% 57 969
Dizziness 1,372 3.7% 13 274
Nausea 1,333 3.6% 20 594
Vomiting 1,201 3.2% 49 769
Acute kidney injury 1,023 2.8% 72 751
Fournier's gangrene 1,000 2.7% 63 681
Diarrhoea 999 2.7% 19 314
Dehydration 973 2.6% 24 581
Pollakiuria 944 2.6% 6 90

Other Indications for EMPAGLIFLOZIN

Product used for unknown indication (16,449) Type 2 diabetes mellitus (12,176) Diabetes mellitus (4,267) Cardiac failure (1,338) Type 1 diabetes mellitus (383) Chronic kidney disease (209) Cardiac failure chronic (172) Cardiac failure congestive (158) Cardiac disorder (157) Blood glucose increased (138)

Other Drugs Used for Diabetes mellitus inadequate control

CANAGLIFLOZIN (121) SEMAGLUTIDE (98) EXENATIDE (74) INSULIN LISPRO (72) LIRAGLUTIDE (66) DULAGLUTIDE (65) INSULIN ASPART (63) INSULIN GLARGINE (54) INSULIN HUMAN (43) METFORMIN (42)

Related Pages

EMPAGLIFLOZIN Full Profile All Diabetes mellitus inadequate control Drugs EMPAGLIFLOZIN Demographics EMPAGLIFLOZIN Timeline